Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Notable open interest changes for December 8th » 08:55
12/08/22
12/08
08:55
12/08/22
08:55
AMZN

Amazon.com

$88.43 /

+0.17 (+0.19%)

, AMC

AMC Entertainment

$6.05 /

-0.705 (-10.44%)

, CVNA

Carvana

$3.82 /

-2.885 (-43.03%)

, TSLA

Tesla

$173.98 /

-5.95 (-3.31%)

Wednesday's total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$88.43 /

+0.17 (+0.19%)

AMC AMC Entertainment
$6.05 /

-0.705 (-10.44%)

CVNA Carvana
$3.82 /

-2.885 (-43.03%)

TSLA Tesla
$173.98 /

-5.95 (-3.31%)

AMZN Amazon.com
$88.43 /

+0.17 (+0.19%)

06:56 Today Citi
DoD contracts shows competitiveness of cloud industry, says Citi
12/06/22 Oppenheimer
Oppenheimer remains very positive on AWS long-term despite macro weakness
12/01/22 Cowen
Amazon.com price target raised to $160 from $150 at Cowen
11/30/22 JMP Securities
JMP Securities encouraged by Amazon.com's focus on innovation
AMC AMC Entertainment
$6.05 /

-0.705 (-10.44%)

11/25/22 Citi
AMC Entertainment price target lowered to $1.10 from $1.20 at Citi
11/06/22 Citi
AMC Entertainment price target lowered to $1.20 from $3.13 at Citi
10/12/22 B. Riley
AMC Entertainment price target lowered to $7.50 from $11 at B. Riley
08/23/22 Wedbush
Wedbush reiterates Underperform rating on AMC Entertainment, cuts target to $2
CVNA Carvana
$3.82 /

-2.885 (-43.03%)

12/07/22 William Blair
Carvana downgraded to Market Perform from Outperform at William Blair
12/07/22 Wedbush
Carvana downgraded to Underperform from Neutral at Wedbush
11/30/22 BofA
BofA downgrades Carvana to Neutral on liquidity concerns
11/30/22 BofA
Carvana downgraded to Neutral from Buy at BofA
TSLA Tesla
$173.98 /

-5.95 (-3.31%)

12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
AMZN Amazon.com
$88.43 /

+0.17 (+0.19%)

AMC AMC Entertainment
$6.05 /

-0.705 (-10.44%)

CVNA Carvana
$3.82 /

-2.885 (-43.03%)

TSLA Tesla
$173.98 /

-5.95 (-3.31%)

  • 22
    Apr
AMZN Amazon.com
$88.43 /

+0.17 (+0.19%)

AMC AMC Entertainment
$6.05 /

-0.705 (-10.44%)

CVNA Carvana
$3.82 /

-2.885 (-43.03%)

TSLA Tesla
$173.98 /

-5.95 (-3.31%)

AMZN Amazon.com
$88.43 /

+0.17 (+0.19%)

AMC AMC Entertainment
$6.05 /

-0.705 (-10.44%)

CVNA Carvana
$3.82 /

-2.885 (-43.03%)

TSLA Tesla
$173.98 /

-5.95 (-3.31%)

AMZN Amazon.com
$88.43 /

+0.17 (+0.19%)

AMC AMC Entertainment
$6.05 /

-0.705 (-10.44%)

CVNA Carvana
$3.82 /

-2.885 (-43.03%)

TSLA Tesla
$173.98 /

-5.95 (-3.31%)

Hot Stocks
Exelixis reports initial results from dose-escalation stage of QUARTZ-101 study » 08:07
12/08/22
12/08
08:07
12/08/22
08:07
EXEL

Exelixis

$16.34 /

-0.345 (-2.07%)

Exelixis announced…

Exelixis announced initial results from the ongoing dose-escalation stage of QUARTZ-101, a phase 1 clinical trial evaluating XL102, a potent, selective, irreversible and orally bioavailable small molecule cyclin-dependent kinase 7, or CDK7, inhibitor, in patients with advanced solid tumors. The data are being presented on Thursday, December 8 during the poster session at 7:00 a.m. CST at the 2022 San Antonio Breast Cancer Symposium, or SABCS. QUARTZ-101 is enrolling patients with solid tumors that are confirmed to be inoperable, locally advanced, metastatic or recurrent. As of the September 7, data cutoff, 26 enrolled patients had been treated with single-agent oral XL102 at five dose levels: 20 mg once daily, 40 mg once daily, 80 mg once daily, 120 mg once daily and 40 mg twice daily. The most common types of cancer for patients enrolled were hormone receptor-positive breast cancer, pancreatic cancer and sarcoma. Median age was 63 years. Seventy-three percent of patients had an Eastern Cooperative Oncology Group score of 1, and 77% had received at least three prior lines of systemic anti-cancer therapy for metastatic disease. A pharmacokinetic analysis demonstrated rapid absorption of XL102 with a Tmax of 1-3 hours and an elimination half-life of 5-9 hours. At day 28, AUC0-24 was doubled with the 40 mg twice-daily dose level versus the 40 mg once-daily dose level, supporting twice-daily oral dosing. Target occupancy was exposure-dependent and prolonged relative to XL102 pharmacokinetics, consistent with covalent binding to CDK7. The median duration of exposure was 9.1 weeks. XL102 was well tolerated at the dose levels evaluated. Dose reductions and dose delays due to a treatment-emergent adverse event occurred in 8% and 35% of patients, respectively; rates were highest with the 80 mg once-daily dose. The most common reasons for discontinuation were radiographic progression, adverse events, lack of clinical benefit and patient request. The most common TEAEs of any grade were diarrhea, nausea, fatigue, anemia and vomiting. TEAEs were generally grade 1 or 2. In the cohort of patients receiving the 40 mg twice-daily dose, one patient experienced dose-limiting toxicity, which was reversible and led to full recovery. Other grade 3 TEAEs were anemia, ascites, blood alkaline phosphatase increased, fatigue, gastric varices, hyperkalemia, hypertension and hypokalemia. There were no grade 5 treatment-related adverse events. The maximum tolerated dose and recommended phase 2 dose have not yet been determined. As of data cutoff, no objective responses had been observed. Two patients with stable disease remain on study treatment as of the data cutoff: one with breast cancer and one with liposarcoma, with treatment durations of 46 and 45 weeks, respectively. One additional patient with breast cancer achieved durable stable disease as the best response and discontinued study treatment at 25 weeks. The efficacy of XL102 will be further evaluated in additional patients in the single-agent dose-escalation cohorts, in the tumor-specific cohort-expansion stage and in planned combination studies.

ShowHide Related Items >><<
EXEL Exelixis
$16.34 /

-0.345 (-2.07%)

EXEL Exelixis
$16.34 /

-0.345 (-2.07%)

11/02/22 Cowen
Exelixis price target lowered to $21 from $26 at Cowen
10/31/22 EF Hutton
Exelixis initiated with a Buy at EF Hutton
10/18/22 JMP Securities
Exelixis initiated with an Outperform at JMP Securities
10/12/22 Guggenheim
Initial data for Exelixis's XB002 show encouraging safety, says Guggenheim
EXEL Exelixis
$16.34 /

-0.345 (-2.07%)

EXEL Exelixis
$16.34 /

-0.345 (-2.07%)

Earnings
KalVista reports Q2 EPS (90c), consensus ($1.06) » 06:32
12/08/22
12/08
06:32
12/08/22
06:32
KALV

KalVista

$5.22 /

+0.17 (+3.37%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KALV KalVista
$5.22 /

+0.17 (+3.37%)

KALV KalVista
$5.22 /

+0.17 (+3.37%)

10/06/22 H.C. Wainwright
KalVista price target lowered to $16 from $48 at H.C. Wainwright
10/05/22 H.C. Wainwright
H.C. Wainwright has more confidence in Astria opportunity after KalVista news
10/04/22 Piper Sandler
Piper says KalVista setback removes overhang for BioCryst's Orladeyo
06/08/22 Stifel
KalVista acute HAE market opportunity 'underappreciated,' says Stifel
KALV KalVista
$5.22 /

+0.17 (+3.37%)

KALV KalVista
$5.22 /

+0.17 (+3.37%)

Yesterday
Hot Stocks
Interest rates, slow economy weigh on U.S. auto dealers, Cox Automotive says » 15:01
12/07/22
12/07
15:01
12/07/22
15:01
F

Ford

$13.14 /

-0.145 (-1.09%)

, GM

General Motors

$37.91 /

-0.1 (-0.26%)

, HMC

Honda

$23.80 /

+0.1 (+0.42%)

, NSANY

Nissan

$6.76 /

+0.01 (+0.15%)

, TM

Toyota

$141.80 /

+1 (+0.71%)

, DDAIF

Mercedes-Benz Group

/

+

, VWAGY

Volkswagen

$19.14 /

-0.23 (-1.19%)

, TSLA

Tesla

$173.17 /

-6.76 (-3.76%)

Atlanta-based Cox…

Atlanta-based Cox Automotive, operator of Manheim car auctions and brands including AutoTrader.com, Kelley Blue Book, said earlier: "U.S. automobile dealer sentiment in the fourth quarter of 2022 dropped to the lowest level since the start of the COVID-19 pandemic, according to the Cox Automotive Dealer Sentiment Index . At 43, the current market index is below the threshold of 50, indicating that more dealers view the current auto market as weak than strong. The index is down 6 points quarter over quarter, down 17 points year over year, and well below the pre-pandemic average of 48.The current market index peaked at 67 in Q2 2021 and has been losing momentum every quarter since. U.S. auto dealers indicate that their negative view of the market is influenced by the economy, higher interest rates and low inventory."High interest rates and a generally slowing economy are clearly weighing heavily on U.S. auto dealers right now," said Jonathan Smoke, Cox Automotive Chief Economist. "Dealers are normally optimistic, so the drop in the 3-month outlook to a new low in our survey history is particularly noteworthy. As the year began, dealers were telling us about one obvious problem: Inventory. Now, as 2022 comes to a close, it's all about the economy and interest rates." Publicly traded companies in the space include Ford (F), General Motors (GM), Honda (HMC), Mercedes-Benz Group (DDAIF), Nissan (NSANY), Stellantis (STLA), Tesla (TSLA), Toyota (TM), Volkswagen (VWAGY). Reference Link

ShowHide Related Items >><<
VWAGY Volkswagen
$19.14 /

-0.23 (-1.19%)

TSLA Tesla
$173.17 /

-6.76 (-3.76%)

TM Toyota
$141.80 /

+1 (+0.71%)

NSANY Nissan
$6.76 /

+0.01 (+0.15%)

HMC Honda
$23.80 /

+0.1 (+0.42%)

GM General Motors
$37.91 /

-0.1 (-0.26%)

F Ford
$13.14 /

-0.145 (-1.09%)

DDAIF Mercedes-Benz Group
/

+

F Ford
$13.14 /

-0.145 (-1.09%)

12/05/22 Jefferies
Fox Factory price target raised to $135 from $120 at Jefferies
12/05/22 Jefferies
Polaris price target raised to $106 from $100 at Jefferies
11/30/22 Citi
Ford price target raised to $14 from $13 at Citi
10/27/22 Morgan Stanley
Ford decision to wind down Argo a positive, says Morgan Stanley
GM General Motors
$37.91 /

-0.1 (-0.26%)

11/18/22 Wedbush
GM's Investor Day event 'impressive,' says Wedbush
11/10/22 Wolfe Research
General Motors downgraded to Peer Perform from Outperform at Wolfe Research
10/26/22 Deutsche Bank
General Motors price target lowered to $35 from $36 at Deutsche Bank
10/26/22 JPMorgan
General Motors price target raised to $59 from $58 at JPMorgan
HMC Honda
$23.80 /

+0.1 (+0.42%)

03/03/22 Morgan Stanley
Other legacy automakers may follow Ford's lead, says Morgan Stanley
12/28/21 BofA
BofA sees December U.S. light vehicle sales down 20%
NSANY Nissan
$6.76 /

+0.01 (+0.15%)

11/28/22 JPMorgan
Nissan downgraded to Neutral from Overweight at JPMorgan
04/25/22 Citi
Nissan collaboration 'clear positive' for Luminar, says Citi
12/15/21 JPMorgan
Nissan upgraded to Overweight from Neutral at JPMorgan
TM Toyota
$141.80 /

+1 (+0.71%)

10/13/22 Citi
Toyota downgraded to Neutral at Citi on lower earnings outlook
10/13/22 Citi
Toyota downgraded to Neutral from Buy at Citi
10/06/22 UBS
Toyota downgraded to Neutral at UBS on lower profit forecasts
10/06/22 UBS
Toyota downgraded to Neutral from Buy at UBS
DDAIF Mercedes-Benz Group
/

+

07/29/22 RBC Capital
Mercedes-Benz Group price target raised to EUR 90 from EUR 89 at RBC Capital
07/07/22 UBS
Mercedes-Benz Group price target lowered to EUR 80 from EUR 90 at UBS
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
05/17/22 Bernstein
Mercedes-Benz Group initiated with an Outperform at Bernstein
VWAGY Volkswagen
$19.14 /

-0.23 (-1.19%)

12/07/22 Morgan Stanley
Volkswagen resumed with an Equal Weight at Morgan Stanley
11/08/22 BofA
Volkswagen upgraded to Buy from Neutral at BofA
11/08/22 Goldman Sachs
Volkswagen reinstated with a Neutral at Goldman Sachs
10/31/22 Deutsche Bank
Volkswagen price target lowered to EUR 200 from EUR 230 at Deutsche Bank
TSLA Tesla
$173.17 /

-6.76 (-3.76%)

12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
VWAGY Volkswagen
$19.14 /

-0.23 (-1.19%)

TSLA Tesla
$173.17 /

-6.76 (-3.76%)

TM Toyota
$141.80 /

+1 (+0.71%)

HMC Honda
$23.80 /

+0.1 (+0.42%)

GM General Motors
$37.91 /

-0.1 (-0.26%)

F Ford
$13.14 /

-0.145 (-1.09%)

DDAIF Mercedes-Benz Group
/

+

VWAGY Volkswagen
$19.14 /

-0.23 (-1.19%)

TSLA Tesla
$173.17 /

-6.76 (-3.76%)

TM Toyota
$141.80 /

+1 (+0.71%)

NSANY Nissan
$6.76 /

+0.01 (+0.15%)

HMC Honda
$23.80 /

+0.1 (+0.42%)

GM General Motors
$37.91 /

-0.1 (-0.26%)

F Ford
$13.14 /

-0.145 (-1.09%)

DDAIF Mercedes-Benz Group
/

+

VWAGY Volkswagen
$19.14 /

-0.23 (-1.19%)

TSLA Tesla
$173.17 /

-6.76 (-3.76%)

TM Toyota
$141.80 /

+1 (+0.71%)

NSANY Nissan
$6.76 /

+0.01 (+0.15%)

HMC Honda
$23.80 /

+0.1 (+0.42%)

GM General Motors
$37.91 /

-0.1 (-0.26%)

F Ford
$13.14 /

-0.145 (-1.09%)

DDAIF Mercedes-Benz Group
/

+

TSLA Tesla
$173.17 /

-6.76 (-3.76%)

GM General Motors
$37.91 /

-0.1 (-0.26%)

F Ford
$13.14 /

-0.145 (-1.09%)

Options
Notable open interest changes for December 7th » 08:55
12/07/22
12/07
08:55
12/07/22
08:55
TSLA

Tesla

$179.94 /

-2.48 (-1.36%)

, BAC

Bank of America

$32.98 /

-1.47 (-4.27%)

, CCL

Carnival

$9.31 /

-0.365 (-3.77%)

, AMZN

Amazon.com

$88.25 /

-2.76 (-3.03%)

Tuesday's total…

Tuesday's total option volume of 42.2 million contracts resulted in net open interest growth of 4.38 million calls and 3.81 million puts. Tesla (TSLA), Bank of America (BAC), Carnival (CCL) and Amazon (AMZN) saw the greatest growth. Top five new positions opened include 39k Warner Bros. Discovery (WBD) 12/9 weekly 10.5 puts, 30k Luminar Technologies (LAZR) 12/9 weekly 7 puts, 30k Carnival (CCL) 12/23 weekly 8.5 puts, 28k Alteryx (AYX) Feb-23 40 calls and 28k Alteryx (AYX) Feb-23 40 puts.

ShowHide Related Items >><<
TSLA Tesla
$179.94 /

-2.48 (-1.36%)

CCL Carnival
$9.31 /

-0.365 (-3.77%)

BAC Bank of America
$32.98 /

-1.47 (-4.27%)

AMZN Amazon.com
$88.25 /

-2.76 (-3.03%)

TSLA Tesla
$179.94 /

-2.48 (-1.36%)

12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
BAC Bank of America
$32.98 /

-1.47 (-4.27%)

11/14/22 Citi
Bank of America downgraded to Neutral from Buy at Citi
11/02/22 JPMorgan
Bank of America price target raised to $39 from $35.50 at JPMorgan
10/18/22 BMO Capital
Bank of America price target raised to $42 from $41 at BMO Capital
10/11/22 JPMorgan
Bank of America price target lowered to $35.50 from $40.50 at JPMorgan
CCL Carnival
$9.31 /

-0.365 (-3.77%)

12/06/22 JPMorgan
Carnival assumed with a Neutral at JPMorgan
11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Carnival price target raised to $16 from $8 at UBS
10/27/22 Tigress Financial
Tigress Financial sees 45% 12-month upside in Carnival shares
AMZN Amazon.com
$88.25 /

-2.76 (-3.03%)

12/06/22 Oppenheimer
Oppenheimer remains very positive on AWS long-term despite macro weakness
12/01/22 Cowen
Amazon.com price target raised to $160 from $150 at Cowen
11/30/22 JMP Securities
JMP Securities encouraged by Amazon.com's focus on innovation
11/29/22 UBS
Affirm initiated with a Neutral at UBS
TSLA Tesla
$179.94 /

-2.48 (-1.36%)

CCL Carnival
$9.31 /

-0.365 (-3.77%)

BAC Bank of America
$32.98 /

-1.47 (-4.27%)

AMZN Amazon.com
$88.25 /

-2.76 (-3.03%)

  • 21
    Jul
TSLA Tesla
$179.94 /

-2.48 (-1.36%)

CCL Carnival
$9.31 /

-0.365 (-3.77%)

BAC Bank of America
$32.98 /

-1.47 (-4.27%)

AMZN Amazon.com
$88.25 /

-2.76 (-3.03%)

TSLA Tesla
$179.94 /

-2.48 (-1.36%)

CCL Carnival
$9.31 /

-0.365 (-3.77%)

BAC Bank of America
$32.98 /

-1.47 (-4.27%)

AMZN Amazon.com
$88.25 /

-2.76 (-3.03%)

TSLA Tesla
$179.94 /

-2.48 (-1.36%)

CCL Carnival
$9.31 /

-0.365 (-3.77%)

BAC Bank of America
$32.98 /

-1.47 (-4.27%)

AMZN Amazon.com
$88.25 /

-2.76 (-3.03%)

Recommendations
Tesla may need to take additional price cuts in 2023, says Bernstein » 06:14
12/07/22
12/07
06:14
12/07/22
06:14
TSLA

Tesla

$179.94 /

-2.48 (-1.36%)

Bernstein analyst Toni…

Bernstein analyst Toni Sacconaghi believes Tesla "increasingly appears to have a demand issue." The company has responded by cutting prices in China and the U.S., and purportedly reducing production in China, he adds. The analyst estimates that price cuts in China and the U.S. this quarter will negatively impact ASPs globally by roughly 2.6% or $1,400 per car. All else equal, this points to a 200 bps decrease in automotive gross margins. Sacconaghi suspects the net impact will be lower, but believes that consensus estimates for automotive gross margins improving 110 bps sequentially in Q4 may be at risk. More importantly, the analyst thinks Tesla may need to take additional price cuts in 2023 in China to stimulate demand, and will need to take permanent cuts in the U.S. to qualify for IRA rebates. Sacconaghi has an Underperform rating and a price target of $150 on the shares.

ShowHide Related Items >><<
TSLA Tesla
$179.94 /

-2.48 (-1.36%)

TSLA Tesla
$179.94 /

-2.48 (-1.36%)

12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
TSLA Tesla
$179.94 /

-2.48 (-1.36%)

TSLA Tesla
$179.94 /

-2.48 (-1.36%)

TSLA Tesla
$179.94 /

-2.48 (-1.36%)

TSLA Tesla
$179.94 /

-2.48 (-1.36%)

Tuesday
Hot Stocks
Vietnam-based EV maker VinFast plans for U.S. IPO » 13:51
12/06/22
12/06
13:51
12/06/22
13:51
TSLA

Tesla

$177.89 /

-4.53 (-2.48%)

, NIO

Nio

$13.02 /

+0.22 (+1.72%)

, LI

Li Auto

$23.23 /

+1.09 (+4.92%)

, XPEV

XPeng

$11.64 /

+0.315 (+2.78%)

, CHPT

ChargePoint

$10.93 /

-0.54 (-4.71%)

, RIVN

Rivian Automotive

$27.63 /

-1.905 (-6.45%)

, GOOG

Alphabet

$97.52 /

-2.4 (-2.40%)

VinFast Trading &…

VinFast Trading & Investment announced that it has publicly filed a registration statement on Form F-1 with the Securities and Exchange Commission or SEC, relating to the proposed initial public offering of its ordinary shares. The number of shares to be offered and the price range for the proposed offering have not yet been determined. VinFast intends to list its ordinary shares on the Nasdaq Global Select Market under the symbol "VFS". Citigroup Global Markets Inc., Morgan Stanley , Credit Suisse and J.P. Morgan Securities will act as lead book-running managers and as representatives of the underwriters for the proposed offering. BofA Securities, Inc., BNP Paribas Securities, HSBC Securities Nomura Securities International, Inc., WR Securities and RBC Capital Markets, will also be book-running managers. Robert W. Baird & Co. Incorporated will act as co-manager for the proposed offering. Publicly listed companies in the EV space include: Tesla (TSLA), Nio (NIO), Li Auto (LI), XPeng (XPEV), ChargePoint (CHPT) , Rivian Automotive (RIVN) and Alphabet (GOOG).

ShowHide Related Items >><<
XPEV XPeng
$11.64 /

+0.315 (+2.78%)

TSLA Tesla
$177.89 /

-4.53 (-2.48%)

RIVN Rivian Automotive
$27.63 /

-1.905 (-6.45%)

NIO Nio
$13.02 /

+0.22 (+1.72%)

LI Li Auto
$23.23 /

+1.09 (+4.92%)

GOOG Alphabet
$97.52 /

-2.4 (-2.40%)

CHPT ChargePoint
$10.93 /

-0.54 (-4.71%)

TSLA Tesla
$177.89 /

-4.53 (-2.48%)

12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
NIO Nio
$13.02 /

+0.22 (+1.72%)

11/28/22 Jefferies
Nio assumed with a Hold at Jefferies
11/21/22 Deutsche Bank
'Worse may finally be over' for Nio, says Deutsche Bank
11/17/22 UBS
Nio downgraded to Neutral at UBS on expectations for ET5 execution challenges
11/17/22 UBS
Nio downgraded to Neutral from Buy at UBS
LI Li Auto
$23.23 /

+1.09 (+4.92%)

11/28/22 Jefferies
Li Auto initiated with a Buy at Jefferies
11/25/22 DBS Bank
Li Auto initiated with a Buy at DBS Bank
10/28/22 Barclays
Li Auto price target lowered to $25 from $40 at Barclays
09/06/22 Morgan Stanley
September 'crunch time' for China EV makers, says Morgan Stanley
XPEV XPeng
$11.64 /

+0.315 (+2.78%)

12/02/22 China Renaissance
XPeng downgraded to Hold from Buy at China Renaissance
11/28/22 Jefferies
XPeng downgraded to Underperform from Hold at Jefferies
11/22/22 DBS Bank
XPeng initiated with a Buy at DBS Bank (earlier)
CHPT ChargePoint
$10.93 /

-0.54 (-4.71%)

12/05/22 DA Davidson
ChargePoint price target lowered to $18 from $20 at DA Davidson
12/02/22 R.F. Lafferty
ChargePoint price target lowered to $28 from $34 at R.F. Lafferty
12/02/22 Oppenheimer
ChargePoint price target lowered to $26 from $40 at Oppenheimer
11/29/22 Citi
ChargePoint price target lowered to $14 from $15.50 at Citi
RIVN Rivian Automotive
$27.63 /

-1.905 (-6.45%)

11/29/22 Evercore ISI
Rivian Automotive initiated with an In Line, $35 target at Evercore ISI
11/29/22 Evercore ISI
Rivian Automotive initiated with an In Line at Evercore ISI
11/10/22 RBC Capital
Rivian Automotive price target lowered to $50 from $61 at RBC Capital
11/10/22 Deutsche Bank
Rivian Automotive price target lowered to $43 from $44 at Deutsche Bank
GOOG Alphabet
$97.52 /

-2.4 (-2.40%)

11/30/22 Societe Generale
Alphabet price target lowered to $132 from $147 at Societe Generale
11/29/22 Lake Street
Google Health partnership 'significant positive' for iCAD, says Lake Street
11/15/22 Morgan Stanley
Alphabet price target lowered to $120 from $125 at Morgan Stanley
11/10/22 BofA
BofA downgrades Viant, sees things getting worse before better
XPEV XPeng
$11.64 /

+0.315 (+2.78%)

TSLA Tesla
$177.89 /

-4.53 (-2.48%)

RIVN Rivian Automotive
$27.63 /

-1.905 (-6.45%)

NIO Nio
$13.02 /

+0.22 (+1.72%)

LI Li Auto
$23.23 /

+1.09 (+4.92%)

GOOG Alphabet
$97.52 /

-2.4 (-2.40%)

CHPT ChargePoint
$10.93 /

-0.54 (-4.71%)

TSLA Tesla
$177.89 /

-4.53 (-2.48%)

RIVN Rivian Automotive
$27.63 /

-1.905 (-6.45%)

NIO Nio
$13.02 /

+0.22 (+1.72%)

LI Li Auto
$23.23 /

+1.09 (+4.92%)

GOOG Alphabet
$97.52 /

-2.4 (-2.40%)

CHPT ChargePoint
$10.93 /

-0.54 (-4.71%)

XPEV XPeng
$11.64 /

+0.315 (+2.78%)

TSLA Tesla
$177.89 /

-4.53 (-2.48%)

RIVN Rivian Automotive
$27.63 /

-1.905 (-6.45%)

NIO Nio
$13.02 /

+0.22 (+1.72%)

LI Li Auto
$23.23 /

+1.09 (+4.92%)

GOOG Alphabet
$97.52 /

-2.4 (-2.40%)

CHPT ChargePoint
$10.93 /

-0.54 (-4.71%)

XPEV XPeng
$11.64 /

+0.315 (+2.78%)

TSLA Tesla
$177.89 /

-4.53 (-2.48%)

RIVN Rivian Automotive
$27.63 /

-1.905 (-6.45%)

NIO Nio
$13.02 /

+0.22 (+1.72%)

LI Li Auto
$23.23 /

+1.09 (+4.92%)

GOOG Alphabet
$97.52 /

-2.4 (-2.40%)

CHPT ChargePoint
$10.93 /

-0.54 (-4.71%)

Options
Notable open interest changes for December 6th » 08:55
12/06/22
12/06
08:55
12/06/22
08:55
TSLA

Tesla

$182.42 /

-12.43 (-6.38%)

, AAPL

Apple

$146.61 /

-1.21 (-0.82%)

, AMZN

Amazon.com

$91.01 /

-3.11 (-3.30%)

, BAC

Bank of America

$34.45 /

-1.62 (-4.49%)

Monday's total…

Monday's total option volume of 40.8 million contracts resulted in net open interest growth of 4.82 million calls and 4.52 million puts. Tesla (TSLA), Apple (AAPL), Amazon (AMZN) and Bank of America (BAC) saw the greatest growth. Top five new positions opened include 40k Luminar Technologies (LAZR) Dec-22 9 calls, 32k Vale (VALE) Jan-23 18 puts, 29k Coinbase (COIN) 12/9 weekly 55 calls, 26k Ares Commercial (ACRE) Feb-23 10 puts and 26k Apollo Commercial (ARI) Feb-23 10 puts.

ShowHide Related Items >><<
TSLA Tesla
$182.42 /

-12.43 (-6.38%)

BAC Bank of America
$34.45 /

-1.62 (-4.49%)

AMZN Amazon.com
$91.01 /

-3.11 (-3.30%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
AMZN Amazon.com
$91.01 /

-3.11 (-3.30%)

12/06/22 Oppenheimer
Oppenheimer remains very positive on AWS long-term despite macro weakness
12/01/22 Cowen
Amazon.com price target raised to $160 from $150 at Cowen
11/30/22 JMP Securities
JMP Securities encouraged by Amazon.com's focus on innovation
11/29/22 UBS
Affirm initiated with a Neutral at UBS
BAC Bank of America
$34.45 /

-1.62 (-4.49%)

11/14/22 Citi
Bank of America downgraded to Neutral from Buy at Citi
11/02/22 JPMorgan
Bank of America price target raised to $39 from $35.50 at JPMorgan
10/18/22 BMO Capital
Bank of America price target raised to $42 from $41 at BMO Capital
10/11/22 JPMorgan
Bank of America price target lowered to $35.50 from $40.50 at JPMorgan
TSLA Tesla
$182.42 /

-12.43 (-6.38%)

BAC Bank of America
$34.45 /

-1.62 (-4.49%)

AMZN Amazon.com
$91.01 /

-3.11 (-3.30%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

BAC Bank of America
$34.45 /

-1.62 (-4.49%)

AMZN Amazon.com
$91.01 /

-3.11 (-3.30%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

BAC Bank of America
$34.45 /

-1.62 (-4.49%)

AMZN Amazon.com
$91.01 /

-3.11 (-3.30%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

BAC Bank of America
$34.45 /

-1.62 (-4.49%)

AMZN Amazon.com
$91.01 /

-3.11 (-3.30%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

Monday
Periodicals
Musk's medical device company Neuralink faces federal probe, Reuters says » 17:53
12/05/22
12/05
17:53
12/05/22
17:53
TSLA

Tesla

$182.42 /

-12.43 (-6.38%)

, TWTR

Twitter

$53.71 /

+ (+0.00%)

Tesla (TSLA) founder, CEO…

Tesla (TSLA) founder, CEO and new Twitter (TWTR) chief, Elon Musk's Neuralink, a medical device company that hopes to help the paralyzed "walk again," is under federal investigation for "potential animal-welfare violations" amid internal staff complaints that its animal testing is "being rushed," causing pain and death that is not necessary, reports Reuters, citing documents reviewed and sources familiar with the investigation and company operations. "The investigation has come at a time of growing employee dissent about Neuralink's animal testing, including complaints that pressure from CEO Musk to accelerate development has resulted in botched experiments, according to a Reuters review of dozens of Neuralink documents and interviews with more than 20 current and former employees," added the Reuters' story. Reference Link

ShowHide Related Items >><<
TWTR Twitter
$53.71 /

+ (+0.00%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
TWTR Twitter
$53.71 /

+ (+0.00%)

10/31/22 Gordon Haskett
Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
10/21/22 Wedbush
Twitter deal still 'brutal situation' for Tesla holders, Wedbush says
10/18/22 Gordon Haskett
Bilson sees Tesla share sale coming with Musk $8B short for Twitter
TWTR Twitter
$53.71 /

+ (+0.00%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

TWTR Twitter
$53.71 /

+ (+0.00%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

TWTR Twitter
$53.71 /

+ (+0.00%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

TWTR Twitter
$53.71 /

+ (+0.00%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

On The Fly
What You Missed On Wall Street On Monday » 16:52
12/05/22
12/05
16:52
12/05/22
16:52
CRM

Salesforce

$133.87 /

-10.695 (-7.40%)

, IOVA

Iovance Biotherapeutics

$8.04 /

+1.195 (+17.46%)

, BP

BP

$35.01 /

-0.355 (-1.00%)

, COP

ConocoPhillips

$119.37 /

-2.385 (-1.96%)

, SHEL

Shell

$57.41 /

-0.29 (-0.50%)

, TTE

TotalEnergies

$59.71 /

-0.97 (-1.60%)

, XOM

Exxon Mobil

$106.80 /

-3.035 (-2.76%)

, CVX

Chevron

$176.63 /

-4.32 (-2.39%)

, USO

United States Oil Fund

$67.71 /

-2.13 (-3.05%)

, VFC

VF Corp.

$29.52 /

-3.7 (-11.14%)

, NBTB

NBT Bancorp

$43.38 /

-2.94 (-6.35%)

, SAL

Salisbury Bancorp

$31.23 /

+0.14 (+0.45%)

, TSLA

Tesla

$182.42 /

-12.43 (-6.38%)

, AAPL

Apple

$146.61 /

-1.21 (-0.82%)

, SBUX

Starbucks

$103.59 /

-1.44 (-1.37%)

, DPZ

Domino's Pizza

$380.98 /

-1.24 (-0.32%)

, UAL

United Airlines

$45.03 /

+1.14 (+2.60%)

, MGM

MGM Resorts

$37.81 /

+0.74 (+2.00%)

, SI

Silvergate Capital

$24.24 /

-2.225 (-8.41%)

, RXT

Rackspace Technology

$4.10 /

-0.75 (-15.48%)

, CVS

CVS Health

$102.01 /

-0.55 (-0.54%)

, PINS

Pinterest

$23.96 /

-0.895 (-3.60%)

, NKE

Nike

$109.64 /

-2.55 (-2.27%)

, CS

Credit Suisse

$3.35 /

-0.035 (-1.04%)

, CWK

Cushman & Wakefield

$12.26 /

+0.295 (+2.47%)

, HZNP

Horizon Therapeutics

$98.55 /

-6.275 (-5.99%)

, JNJ

Johnson & Johnson

$178.79 /

-0.05 (-0.03%)

, FTCH

Farfetch

$5.45 /

-0.54 (-9.02%)

, SAIC

SAIC

$113.98 /

+5.145 (+4.73%)

, VERU

Veru

$5.80 /

+0.295 (+5.36%)

, SLG

SL Green Realty

$38.07 /

-2.58 (-6.35%)

, ENLV

Enlivex Therapeutics

$4.41 /

-0.07 (-1.56%)

, NTRB

Nutriband

$3.82 /

+0.045 (+1.19%)

Get caught up quickly on…

ShowHide Related Items >><<
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

12/05/22 KeyBanc
Veeva price target lowered to $210 from $220 at KeyBanc
12/05/22 Credit Suisse
Salesforce price target lowered to $225 from $250 at Credit Suisse
12/05/22 Citi
Salesforce price target lowered to $164 from $170 at Citi
12/02/22 Morgan Stanley
Veeva assumed with an Equal Weight at Morgan Stanley
IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

11/21/22 JMP Securities
Iovance Biotherapeutics price target lowered to $21 from $25 at JMP Securities
11/20/22 Piper Sandler
Iovance Biotherapeutics price target lowered to $11 from $13 at Piper Sandler
11/18/22 Chardan
Iovance Biotherapeutics price target lowered to $29 from $30 at Chardan
11/18/22 Oppenheimer
Iovance price target lowered to $25 from $27 at Oppenheimer
BP BP
$35.01 /

-0.355 (-1.00%)

12/02/22 JPMorgan
BP price target raised to 560 GBp from 530 GBp at JPMorgan
11/22/22 Citi
BP upgraded to Buy from Neutral at Citi
11/14/22 Wells Fargo
Archaea Energy downgraded to Equal Weight from Overweight at Wells Fargo
11/11/22 Piper Sandler
BP price target raised to $40 from $37 at Piper Sandler
COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

11/22/22 Citi
ConocoPhillips price target raised to $160 from $132 at Citi
11/21/22 Argus
ConocoPhillips price target raised to $150 from $125 at Argus
11/21/22 Societe Generale
ConocoPhillips downgraded to Sell on valuation at Societe Generale
11/21/22 Societe Generale
ConocoPhillips downgraded to Sell from Hold at Societe Generale
SHEL Shell
$57.41 /

-0.29 (-0.50%)

12/02/22 JPMorgan
Shell price target raised to 2,950 GBp from 2,900 GBp at JPMorgan
11/11/22 Piper Sandler
Shell price target raised to $71 from $65 at Piper Sandler
11/08/22 Morgan Stanley
Shell price target raised to 2,922 GBp from 2,860 GBp at Morgan Stanley
11/06/22 Goldman Sachs
Shell downgraded to Neutral from Buy at Goldman Sachs
TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

12/02/22 JPMorgan
TotalEnergies price target raised to EUR 68 from EUR 66 at JPMorgan
12/02/22 JPMorgan
TotalEnergies added to Analyst Focus List at JPMorgan
11/11/22 Piper Sandler
TotalEnergies price target raised to $66 from $58 at Piper Sandler
11/08/22 Morgan Stanley
TotalEnergies price target raised to EUR 65 from EUR 58 at Morgan Stanley
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

11/22/22 Citi
Exxon Mobil price target raised to $110 from $98 at Citi
11/11/22 Piper Sandler
Exxon Mobil price target raised to $131 from $113 at Piper Sandler
11/01/22 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
10/31/22 Truist
Exxon Mobil price target raised to $114 from $111 at Truist
CVX Chevron
$176.63 /

-4.32 (-2.39%)

11/22/22 Citi
Chevron price target raised to $180 from $155 at Citi
11/11/22 Piper Sandler
Chevron price target raised to $206 from $186 at Piper Sandler
10/31/22 Cowen
Chevron price target raised to $185 from $160 at Cowen
10/24/22 HSBC
Chevron downgraded to Hold from Buy at HSBC
USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

12/06/22 Baird
VF Corp. removed from bullish Fresh Pick at Baird
12/05/22 Deutsche Bank
VF Corp. risk/reward favorable with bar reset, says Deutsche Bank
12/05/22 Credit Suisse
Credit Suisse downgrades VF Corp. after 'abrupt' CEO transition
12/05/22 Credit Suisse
VF Corp. downgraded to Neutral from Outperform at Credit Suisse
NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

12/06/22 Janney Montgomery Scott
Salisbury Bancorp downgraded to Neutral at Janney after NBT Bancorp deal
01/09/22 Keefe Bruyette
NBT Bancorp assumed with a Market Perform at Keefe Bruyette
SAL Salisbury Bancorp
$31.23 /

+0.14 (+0.45%)

12/06/22 Janney Montgomery Scott
Salisbury Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott
TSLA Tesla
$182.42 /

-12.43 (-6.38%)

12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/23/22 Morgan Stanley
Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
AAPL Apple
$146.61 /

-1.21 (-0.82%)

12/05/22 Wedbush
Apple shift out of China will not be easy, says Wedbush
12/02/22 Morgan Stanley
Morgan Stanley sees December quarter App Store forecast as 'conservative'
12/01/22 Piper Sandler
Apple estimates lowered on shutdowns in Zhengzhou at Piper Sandler
11/30/22 Wedbush
China lockdown ends in iPhone city, heavy lifting ahead for Apple, says Wedbush
SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

12/05/22 Deutsche Bank
Starbucks downgraded to Hold from Buy at Deutsche Bank
11/04/22 Evercore ISI
Starbucks price target raised to $97 from $95 at Evercore ISI
11/04/22 Citi
Starbucks price target raised to $93 from $90 at Citi
11/04/22 Wedbush
Starbucks price target raised to $96 from $92 at Wedbush
DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

12/05/22 BTIG
Domino's Pizza upgraded to Buy from Neutral at BTIG
11/30/22 Citi
Domino's Pizza price target raised to $441 from $407 at Citi
11/18/22 Northcoast
Domino's Pizza upgraded to Buy from Neutral at Northcoast
10/14/22 BMO Capital
Domino's Pizza price target lowered to $400 from $430 at BMO Capital
UAL United Airlines
$45.03 /

+1.14 (+2.60%)

12/06/22 Argus
United Airlines upgraded to Buy from Hold at Argus
12/05/22 Morgan Stanley
United Airlines upgraded to Overweight from Equal Weight at Morgan Stanley
10/25/22 Cowen
Mesa Air price target lowered to $1.50 from $4.00 at Cowen
10/21/22 Citi
United Airlines price target raised to $65 from $56 at Citi
MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

12/05/22 Truist
MGM Resorts upgraded to Buy at Truist amid returning activity at the Strip
12/05/22 Truist
MGM Resorts upgraded to Buy from Hold at Truist
11/28/22 Jefferies
Macau concession renewals removes overhang for incumbents, says Jefferies
11/28/22 JPMorgan
DraftKings downgraded to Underweight from Neutral at JPMorgan
SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

12/05/22 Morgan Stanley
Silvergate Capital downgraded to Underweight from Equal Weight at Morgan Stanley
11/29/22 Keefe Bruyette
Silvergate exposure to BlockFi 'very modest,' says Keefe Bruyette
11/25/22 Morgan Stanley
Silvergate Capital price target lowered to $24 from $37 at Morgan Stanley
11/22/22 BTIG
Silvergate Capital price target lowered to $51 from $135 at BTIG
RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

11/21/22 Citi
Rackspace Technology price target lowered to $5 from $7 at Citi
11/10/22 Deutsche Bank
Rackspace Technology price target lowered to $5 from $6 at Deutsche Bank
10/11/22 Evercore ISI
Rackspace Technology downgraded to In Line at Evercore ISI on 2023 risks
10/11/22 Evercore ISI
Rackspace Technology downgraded to In Line from Outperform at Evercore ISI
CVS CVS Health
$102.01 /

-0.55 (-0.54%)

11/23/22 Morgan Stanley
CVS Health assumed with an Overweight at Morgan Stanley
11/21/22 Credit Suisse
CVS Health price target raised to $125 from $117 at Credit Suisse
11/06/22 Raymond James
CVS Health price target lowered to $115 from $120 at Raymond James
11/02/22 B. Riley
B. Riley downgrades Semler Scientific on risk from Signify buyout
PINS Pinterest
$23.96 /

-0.895 (-3.60%)

10/31/22 Citi
Pinterest price target raised to $26 from $25 at Citi
10/28/22 Stifel
Pinterest 'a rare bright spot thus far through earnings,' says Stifel
10/28/22 Barclays
Pinterest price target raised to $25 from $23 at Barclays
10/28/22 Piper Sandler
Pinterest price target raised to $25 from $23 at Piper Sandler
NKE Nike
$109.64 /

-2.55 (-2.27%)

11/22/22 Cowen
Nike price target raised to $118 from $114 at Cowen
11/07/22 Stifel
Deckers Brands price target raised to $416 from $390 at Stifel
10/13/22 Raymond James
Nike initiated with an Outperform at Raymond James
10/12/22 Raymond James
Nike initiated with an Outperform at Raymond James
CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

12/01/22 JPMorgan
Credit Suisse price target lowered to CHF 3.80 from CHF 5.50 at JPMorgan
11/07/22 AlphaValue/Baader
Credit Suisse downgraded to Sell from Buy at AlphaValue/Baader
10/28/22 JPMorgan
Credit Suisse price target lowered to CHF 5.50 from CHF 6 at JPMorgan
10/06/22 JPMorgan
Credit Suisse upgraded to Neutral from Underweight at JPMorgan
CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

07/22/22 Raymond James
Cushman & Wakefield removed from Analyst Current Favorites list at Raymond James
04/21/22 Citi
Cushman & Wakefield price target lowered to $21 from $23 at Citi
04/05/22 Goldman Sachs
Cushman & Wakefield initiated with a Buy at Goldman Sachs
03/10/22 Wolfe Research
Cushman & Wakefield price target lowered to $28 from $44 at Wolfe Research
HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
11/30/22 Cowen
Horizon Therapeutics takeout in $120-$140 range reasonable, says Cowen
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/01/22 H.C. Wainwright
Horizon Therapeutics initiated with a Neutral at H.C. Wainwright
JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

12/05/22 Cowen
Farfetch price target lowered to $8 from $11 at Cowen
12/02/22 Wells Fargo
Farfetch price target lowered to $18 from $25 at Wells Fargo
12/02/22 JPMorgan
Farfetch selloff on financial outlook overdone, says JPMorgan
12/02/22 BTIG
Farfetch price target lowered to $10 from $13 at BTIG
SAIC SAIC
$113.98 /

+5.145 (+4.73%)

12/06/22 Truist
SAIC price target raised to $120 from $105 at Truist
12/06/22 Wells Fargo
SAIC price target raised to $121 from $99 at Wells Fargo
12/05/22 Stifel
SAIC price target raised to $110 from $99 at Stifel
11/17/22 Jefferies
SAIC downgraded to Hold at Jefferies on lower growth than peers
VERU Veru
$5.80 /

+0.295 (+5.36%)

11/10/22 H.C. Wainwright
Veru price target lowered to $21 from $24 at H.C. Wainwright
09/20/22 Oppenheimer
Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged'
09/08/22 Oppenheimer
Oppenheimer remains bullish on Veru, optimism for EUA unchanged
08/11/22 Cantor Fitzgerald
Veru price target raised to $30 from $24 at Cantor Fitzgerald
SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

12/06/22 Scotiabank
Scotiabank downgrades SL Green with balance sheet looking 'stressed'
12/06/22 BMO Capital
SL Green Realty downgraded to Market Perform from Outperform at BMO Capital
12/06/22 Scotiabank
SL Green Realty downgraded to Underperform from Sector Perform at Scotiabank
11/23/22 Morgan Stanley
SL Green Realty price target lowered to $38 from $44 at Morgan Stanley
ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

05/02/22 H.C. Wainwright
Enlivex Therapeutics price target lowered to $15 from $33 at H.C. Wainwright
NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NTRB Nutriband
$3.82 /

+0.045 (+1.19%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

NBTB NBT Bancorp
$43.38 /

-2.94 (-6.35%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

  • 07
    Dec
XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

TTE TotalEnergies
$59.71 /

-0.97 (-1.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

SAIC SAIC
$113.98 /

+5.145 (+4.73%)

RXT Rackspace Technology
$4.10 /

-0.75 (-15.48%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

ENLV Enlivex Therapeutics
$4.41 /

-0.07 (-1.56%)

CWK Cushman & Wakefield
$12.26 /

+0.295 (+2.47%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

XOM Exxon Mobil
$106.80 /

-3.035 (-2.76%)

VFC VF Corp.
$29.52 /

-3.7 (-11.14%)

VERU Veru
$5.80 /

+0.295 (+5.36%)

USO United States Oil Fund
$67.71 /

-2.13 (-3.05%)

UAL United Airlines
$45.03 /

+1.14 (+2.60%)

TSLA Tesla
$182.42 /

-12.43 (-6.38%)

SLG SL Green Realty
$38.07 /

-2.58 (-6.35%)

SI Silvergate Capital
$24.24 /

-2.225 (-8.41%)

SHEL Shell
$57.41 /

-0.29 (-0.50%)

SBUX Starbucks
$103.59 /

-1.44 (-1.37%)

PINS Pinterest
$23.96 /

-0.895 (-3.60%)

NKE Nike
$109.64 /

-2.55 (-2.27%)

MGM MGM Resorts
$37.81 /

+0.74 (+2.00%)

JNJ Johnson & Johnson
$178.79 /

-0.05 (-0.03%)

IOVA Iovance Biotherapeutics
$8.04 /

+1.195 (+17.46%)

HZNP Horizon Therapeutics
$98.55 /

-6.275 (-5.99%)

FTCH Farfetch
$5.45 /

-0.54 (-9.02%)

DPZ Domino's Pizza
$380.98 /

-1.24 (-0.32%)

CVX Chevron
$176.63 /

-4.32 (-2.39%)

CVS CVS Health
$102.01 /

-0.55 (-0.54%)

CS Credit Suisse
$3.35 /

-0.035 (-1.04%)

CRM Salesforce
$133.87 /

-10.695 (-7.40%)

COP ConocoPhillips
$119.37 /

-2.385 (-1.96%)

BP BP
$35.01 /

-0.355 (-1.00%)

AAPL Apple
$146.61 /

-1.21 (-0.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.